Prihlásiť sa Zaregistrujte sa zadarmo

SMA 50 spoločnosti Affimed N.V

Aká je hodnota metriky SMA 50 spoločnosti Affimed N.V?

Hodnota metriky SMA 50 spoločnosti Affimed N.V. je $5 -17.97%

Aká je definícia metriky SMA 50?



SMA 50 (Simple Moving Average 50) je priemerná cena akcie za posledných 50 dní vypočítaná ako nevážený priemer z predchádzajúcich 50 záverečných cien.

Simple moving average of 50 days for a stock is an unweighted moving average over the past 50 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.

Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.

SMA 50 spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Affimed N.V

Čomu sa venuje spoločnosť Affimed N.V?

affimed (symbol: afmd) is a nasdaq-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. immuno-oncology represents a highly promising approach to cancer treatment that seeks to harness the body’s own immune defenses to attack and destroy tumor cells. natural killer cells, or nk-cells, and t-cells belong to the most potent cells of the human defense arsenal. affimed’s proprietary, next-generation bispecific antibodies, termed tandabs®, are designed to bring nk-cells or t-cells into close proximity to cancer cells that ultimately triggers a signal cascade that leads to the destruction of cancer cells. due to their novel tetravalent tandem architecture, which provides for four binding domains, the tandabs bind to specific targets on immune and cancer cells with high affinity. in addition, tandabs exhibit kinetic properties allowing the administration as regular intravenous infusion and fine-tuning of dosing. affimed beli

Firmy s metrikou sma 50 podobnou spoločnosti Affimed N.V